aspirin and gefarnate

aspirin has been researched along with gefarnate in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hara, N; Okabe, S	1
Fujisaki, H; Murakami, M; Ohgo, T; Okabe, S; Oketani, K; Wakabayashi, T	1
Abe, S; Ashida, K; Chiba, T; Hiramatsu, N; Itabashi, T; Kanto, T; Matsui, S; Matsumoto, Y; Mizokami, Y; Sakaki, N; Shimada, K; Sugano, K; Uchiyama, S; Uemura, N	1
Azuma, T; Fujisawa, T; Fujita, T; Hayakumo, T; Inokuchi, H; Kawai, T; Kutsumi, H; Kuwayama, H; Matsubara, Y; Miyaji, H; Murakami, M; Sanuki, T; Terao, S; Yamazaki, Y; Yoshida, S	1

Trials

2 trial(s) available for aspirin and gefarnate

Article	Year
Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. Journal of gastroenterology, 2011, Volume: 46, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Aspirin; Double-Blind Method; Duodenal Ulcer; Female; Follow-Up Studies; Gefarnate; Humans; Incidence; Japan; Kaplan-Meier Estimate; Lansoprazole; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Secondary Prevention; Stomach Ulcer	2011
Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial. Journal of gastroenterology, 2012, Volume: 47, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Esophagitis; Female; Gefarnate; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Prospective Studies; Rabeprazole; Secondary Prevention	2012

Article

Year

Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.

Journal of gastroenterology, 2011, Volume: 46, Issue:6

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Aspirin; Double-Blind Method; Duodenal Ulcer; Female; Follow-Up Studies; Gefarnate; Humans; Incidence; Japan; Kaplan-Meier Estimate; Lansoprazole; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Secondary Prevention; Stomach Ulcer

2011

Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial.

Journal of gastroenterology, 2012, Volume: 47, Issue:11

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Esophagitis; Female; Gefarnate; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Prospective Studies; Rabeprazole; Secondary Prevention

2012

Other Studies

2 other study(ies) available for aspirin and gefarnate

Article	Year
[Effects of gefarnate on acute gastric lesions in rats]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1985, Volume: 85, Issue:6 Topics: Acute Disease; Animals; Aspirin; Cimetidine; Ethanol; Gefarnate; Male; Rats; Rats, Inbred Strains; Stomach Diseases; Taurocholic Acid; Terpenes	1985
Effects of the antiulcer drug geranylgeranylacetone on aspirin-induced gastric ulcers in rats. Japanese journal of pharmacology, 1982, Volume: 32, Issue:2 Topics: Animals; Aspirin; Diterpenes; Gastric Mucosa; Gefarnate; Hexosamines; Male; Rats; Rats, Inbred Strains; Stomach Ulcer	1982